C

Clinilabs | New Jersey

Research site

(Unclaimed)

Location

4 Industrial Way West 2nd Floor, Eatontown, New Jersey, United States of America

Site insights

Top conditions

Top treatments

PF-06291874

LY03005

BPM31510

DT-216

MK-6552-003

INZ-701

Dexmedetomidine

Nomlabofusp

PF-07261271

MK-6552

Parent organization

This site is a part of Clinilabs

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 19 total trials

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

This Phase 2 study (protocol number VLS-01-203) will determine the efficacy, safety, and tolerability of short-term treatment with a VLS-01 transmuco...

Enrolling

Treatment Resistant Depression

Drug: VLS-01-BU Placebo

Drug: VLS-01-203 BU

A Study to Evaluate the Efficacy and Safety of Subcutaneous Nomlabofusp in Subjects With Friedreich's Ataxia (FORWARD-FA)

To evaluate the efficacy and safety of subcutaneous nomlabofusp in adult and pediatric subjects with Friedreich's ataxia

Enrolling

Friedreich's Ataxia

Friedreich Ataxia

Drug: Placebo

Drug: Nomlabofusp

ENA-001 for Opioid Induced Respiratory Depression

This study is a Phase I clinical trial to assess the safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles with single int...

Enrolling

Respiratory Depression

Drug: ENA-001

Drug: Placebo Comparator

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

A major challenge to seeking treatment for opioid use disorder (OUD) is the withdrawal symptoms associated with cessation of opioid use. The signs an...

Active, not recruiting

Opioid Withdrawal

Opioid Use Disorder

Other: Placebo

Drug: BXCL501 (240 micrograms)